Cargando…
Palonosetron as an anti-emetic and anti-nausea agent in oncology
Palonosetron (Aloxi(®), Onicit(®), Paloxi(®)) is a second-generation 5-HT(3) receptor antagonist (RA) with an extended half-life of ~40 hours and high binding affinity for the 5-HT(3) receptor that is markedly different from other 5-HT(3) RAs. Phase III trials demonstrate that a single dose of palon...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387285/ https://www.ncbi.nlm.nih.gov/pubmed/18516316 |